Insulet | PODD - 资产

金融业

USD

USD 2.99B

现金及等价物

USD 480.4M

USD 232.7M

USD 1.71B

USD 687.5M

USD 949.2M

USD 122M

USD 181.7M

3.9K

EPS每股收益

USD 1.42

股本和储备

USD 1.3B

USD 540.8M

债务利息支出

USD 14.7M

USD 5.7M

USD 929.5M

USD 11.64B

USD 91.1M

USD 639.7M

USD 122M

普通股股本

USD 69.26M

38.83

USD 113M

USD 761.7M

销售和管理费用

USD 317.2M

USD 462.5M

贸易债权人

USD 149.8M

应收帐款人

USD 544.7M

	资产	更改		日
Abbott	USD 110.43B		23.72B	2026-03
Align Technology	USD 6.31B		80.48M	2026-03
AtriCure	USD 676.64M		32.66M	2026-06
Avanos Medical	USD 1.05B		23.6M	2026-03
Baxter International	USD 19.85B		209M	2026-03
Becton, Dickinson and Co.	USD 50.83B		4.01B	2026-03
Boston Scientific	USD 44.35B		678M	2026-03
Cardinal Health	USD 56.69B		1.39B	2026-03
Cooper Companies	USD 12.48B		58.1M	2026-03
Dexcom	USD 6.63B		293.4M	2026-03
Edwards Lifesciences	USD 13.32B		376M	2026-03
Eli Lilly	USD 116.58B		4.1B	2026-03
Globus Medical	USD 5.44B		136.79M	2026-03
ICU Medical	USD 4.01B		36.74M	2026-03
Inogen	USD 307.01M		5.03M	2025-09
Insulet	USD 2.99B		203.2M	2026-03
Integra LifeSciences	USD 3.58B		24.28M	2026-03
J&J	USD 201.06B		167M	2026-06
Medtronic	USD 91.48B		139M	2025-12
Merit Medical Systems	USD 2.72B		33.36M	2026-03
Roche Holding	CHF 98.2B		2.5B	2026-06
Solventum Corp	USD 14.1B		197M	2026-03
Stryker	USD 46.29B		1.55B	2026-03
Tandem Diabetes Care	USD 1.15B		272.28M	2026-03
Teleflex	USD 6.78B		164.24M	2026-03
West Pharmaceutical Services	USD 4.08B		33.4M	2026-06
Zimmer Biomet Holdings	USD 22.72B		370.1M	2026-03